Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Ølgod BioEnergi ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   0.3% 0.3% 0.3% 0.3% 0.3% 0.3% 0.3% 0.3%   Bankruptcy risk   2.6% 2.0% 0.9% 0.7% 0.4% 0.4% 7.6% 7.5%   Credit score (0-100)   63 69 87 94 99 100 32 33   Credit rating   BBB A A AA AAA AAA BB BB   Credit limit (kDKK)   0.0 0.5 1,213.9 4,265.4 5,086.4 4,209.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -91.0 2,940 14,359 29,268 17,310 8,754 0.0 0.0   EBITDA   -92.0 1,894 13,597 28,095 15,741 7,123 0.0 0.0   EBIT   -97.0 -58.0 10,561 25,040 12,652 3,869 0.0 0.0   Pre-tax profit (PTP)   -97.0 -1,245.0 9,484.5 24,191.0 12,173.2 3,882.0 0.0 0.0   Net earnings   -76.0 -972.0 7,383.5 18,868.8 9,494.8 3,022.8 0.0 0.0   Pre-tax profit without non-rec. items   -97.0 -1,245 9,484 24,191 12,173 3,882 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   47,212 58,880 56,327 53,172 54,364 51,454 0.0 0.0   Shareholders equity total   3,937 2,965 10,348 28,073 35,280 36,015 32,727 32,727   Interest-bearing liabilities   45,653 47,617 38,184 22,933 19,894 16,439 0.0 0.0   Balance sheet total (assets)   50,623 71,501 67,324 77,679 74,566 69,686 32,727 32,727   Net Debt   45,634 47,617 37,171 17,962 6,104 10,880 -32,727 -32,727     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -91.0 2,940 14,359 29,268 17,310 8,754 0.0 0.0   Gross profit growth   -97.8% 0.0% 388.4% 103.8% -40.9% -49.4% -100.0% 0.0%   Employees   1 2 2 2 3 3 0 0   Employee growth %   0.0% 100.0% 0.0% 0.0% 50.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   50,623 71,501 67,324 77,679 74,566 69,686 32,727 32,727   Balance sheet change%   14,240.8% 41.2% -5.8% 15.4% -4.0% -6.5% -53.0% 0.0%   Added value   -92.0 1,894.0 13,596.6 28,095.4 15,707.2 7,123.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   46,879 9,716 -5,589 -6,210 -1,897 -6,165 -51,454 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 -3.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   106.6% -2.0% 73.5% 85.6% 73.1% 44.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -0.4% -0.1% 15.2% 34.5% 16.6% 5.8% 0.0% 0.0%   ROI %   -0.4% -0.1% 20.7% 47.9% 22.6% 7.3% 0.0% 0.0%   ROE %   -3.8% -28.2% 110.9% 98.2% 30.0% 8.5% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   31.5% 20.9% 33.4% 36.3% 47.6% 51.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -49,602.2% 2,514.1% 273.4% 63.9% 38.8% 152.7% 0.0% 0.0%   Gearing %   1,159.6% 1,606.0% 369.0% 81.7% 56.4% 45.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 2.5% 2.5% 2.8% 2.2% 1.7% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   0.6 0.5 1.2 1.1 1.9 1.7 0.0 0.0   Current Ratio   0.6 0.7 1.4 1.5 2.1 2.4 0.0 0.0   Cash and cash equivalent   19.0 0.0 1,013.0 4,970.4 13,790.4 5,558.8 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -2,698.0 -4,218.0 2,911.2 8,329.1 10,572.2 10,724.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -92 947 6,798 14,048 5,236 2,374 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -92 947 6,798 14,048 5,247 2,374 0 0   EBIT / employee   -97 -29 5,280 12,520 4,217 1,290 0 0   Net earnings / employee   -76 -486 3,692 9,434 3,165 1,008 0 0